Phase 3 Allograft Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
AERIAL Trial: Antiplatelet Therapy in Heart Transplantation
Heart TransplantCardiac Allograft Vasculopathy
Ottawa Heart Institute Research Corporation135 enrolled3 locationsNCT04770012
Recruiting
Phase 3
A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications
Renal Allograft Recipients
Bristol-Myers Squibb102 enrolled38 locationsNCT04877288
Recruiting
Phase 3
Budesonide versus prednisolone after liver transplantation: a phase 3, open label, non-inferiority randomised controlled trial
Allograft rejection
Austin Health100 enrolled1 locationACTRN12623000340639